[Treatment of trigeminal neuralgia with spasmolytics].
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D005013:Ethosuximide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000188:drug therapy*
D000927:Anticonvulsants; D009025:Morpholines; D011760:Pyrrolidinones; D002220:Carbamazepine; D005013:Ethosuximide
Lechenie trigeminal'noĭ nevralgii protivosudorozhnymi preparatami